Biodegradable self-assembled nanoparticles of poly (d,l-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer

Biomaterials

Volumn 35, Issue 1, 2014, Pages 550-566

  Huang, Jingbin ^a   Zhang, He ^a   Yu, Yuan ^a   Chen, Yan ^a   Wang, Dong ^b   Zhang, Guoqing ^d   Zhou, Guichen ^d   Liu, Junjie ^a   Sun, Zhiguo ^a   Sun, Duxin ^c   Lu, Ying ^a   Zhong, Yanqiang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Beidaihe Sanatorium of Beijing Military Area Command ^*  (China)

^c UNIVERSITY OF MICHIGAN   (United States)

^d EASTERN HEPATOBILIARY SURGERY HOSPITAL   (China)

Author keywords

Breast cancer; CD44; Docetaxel; Hyaluronic acid; Poly (d,l lactide co glycolide); Self assembled nanoparticles

Indexed keywords

BREAST CANCER; CD44; DOCETAXEL; POLY(D ,L-LACTIDE-CO- GLYCOLIDE); SELF ASSEMBLED NANOPARTICLES;

BLOCK COPOLYMERS; CHEMOTHERAPY; DISEASES; DRUG PRODUCTS; HYALURONIC ACID; MOLECULAR BIOLOGY; NANOPARTICLES; ORGANIC ACIDS;

SYNTHESIS (CHEMICAL);

COPOLYMER; DOCETAXEL; HYALURONIC ACID; NANOPARTICLE; POLYGLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BREAST CANCER; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL VIABILITY; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG STABILITY; ENDOCYTOSIS; FEMALE; GENE OVEREXPRESSION; HYDRODYNAMICS; IN VIVO STUDY; MALE; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; PH; PLASMA HALF LIFE; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SUSTAINED DRUG RELEASE; ZETA POTENTIAL;

BREAST CANCER; CD44; DOCETAXEL; HYALURONIC ACID; POLY (D,L-LACTIDE-CO-GLYCOLIDE); SELF-ASSEMBLED NANOPARTICLES;

ANIMALS; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; BIOCOMPATIBLE MATERIALS; BREAST NEOPLASMS; CARBOHYDRATE SEQUENCE; CELL LINE, TUMOR; DRUG CARRIERS; FEMALE; FLOW CYTOMETRY; HUMANS; HYALURONIC ACID; LACTIC ACID; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NANOPARTICLES; POLYGLYCOLIC ACID; RATS; RATS, SPRAGUE-DAWLEY; TAXOIDS;

EID: 84887016122     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.09.089     Document Type: Article

References (42)

1. Gong C., Wei X., Wang X., Wang Y., Guo G., Mao Y., et al. Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic honokiol delivery: I. Preparation and characterization. Nanotechnology 2010, 21:215103.
2. Wei X., Gong C., Shi S., Fu S., Men K., Zeng S., et al. Self-assembled honokiol-loaded micelles based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer. Int J Pharm 2009, 369:170-175.
3. Qu T., Wang A., Yuan J., Gao Q. Preparation of an amphiphilic triblock copolymer with pH- and thermo-responsiveness and self-assembled micelles applied to drug release. JColloid Interface Sci 2009, 336:865-871.
4. Endres T.K., Beck-Broichsitter M., Samsonova O., Renette T., Kissel T.H. Self-assembled biodegradable amphiphilic PEG-PCL-lPEI triblock copolymers at the borderline between micelles and nanoparticles designed for drug and gene delivery. Biomaterials 2011, 32:7721-7731.
5. Cho H.J., Yoon I.S., Yoon H.Y., Koo H., Jin Y.J., Ko S.H., et al. Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin. Biomaterials 2012, 33:1190-1200.
6. Zhang Z., Feng S.S. The drug encapsulation efficiency, invitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials 2006, 27:4025-4033.
7. Pan J., Feng S.S. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles. Biomaterials 2008, 29:2663-2672.
8. Fakhari A., Baoum A., Siahaan T.J., Le K.B., Berkland C. Controlling ligand surface density optimizes nanoparticle binding to ICAM-1. JPharm Sci 2011, 100:1045-1056.
9. Simone E., Dziubla T., Shuvaev V., Muzykantov V.R. Synthesis and characterization of polymer nanocarriers for the targeted delivery of therapeutic enzymes. Methods Mol Biol 2010, 610:145-164.
10. Dharap S.S., Wang Y., Chandna P., Khandare J.J., Qiu B., Gunaseelan S., et al. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc Natl Acad Sci U S A 2005, 102:12962-12967.
11. Jeyarajan S., Xavier J., Rao N.M., Gopal V. Plasmid DNA delivery into MDA-MB-453 cells mediated by recombinant Her-NLS fusion protein. Int J Nanomedicine 2010, 5:725-733.
12. Roulon T., Helene C., Escude C. Coupling of a targeting peptide to plasmid DNA using a new type of padlock oligonucleotide. Bioconjug Chem 2002, 13:1134-1139.
13. Kratz F., Elsadek B. Clinical impact of serum proteins on drug delivery. JControl Release 2012, 161:429-445.
14. Koopaei M.N., Dinarvand R., Amini M., Rabbani H., Emami S., Ostad S.N., et al. Docetaxel immunonanocarriers as targeted delivery systems for HER 2-positive tumor cells: preparation, characterization, and cytotoxicity studies. Int J Nanomedicine 2011, 6:1903-1912.
15. Rothdiener M., Beuttler J., Messerschmidt S.K., Kontermann R.E. Antibody targeting of nanoparticles to tumor-specific receptors: immunoliposomes. Methods Mol Biol 2010, 624:295-308.
16. Jeong J.H., Lee M., Kim W.J., Yockman J.W., Park T.G., Kim Y.H., et al. Anti-GAD antibody targeted non-viral gene delivery to islet beta cells. JControl Release 2005, 107:562-570.
17. Jiskoot W., van Schie R.M., Carstens M.G., Schellekens H. Immunological risk of injectable drug delivery systems. Pharm Res 2009, 26:1303-1314.
18. Orava E.W., Cicmil N., Gariepy J. Delivering cargoes into cancer cells using DNA aptamers targeting internalized surface portals. Biochim Biophys Acta 2010, 1798:2190-2200.
19. Choi K.Y., Chung H., Min K.H., Yoon H.Y., Kim K., Park J.H., et al. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials 2010, 31:106-114.
20. Cho H.J., Yoon H.Y., Koo H., Ko S.H., Shim J.S., Lee J.H., et al. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic(R) for tumor-targeted delivery of docetaxel. Biomaterials 2011, 32:7181-7190.
21. Mizrahy S., Raz S.R., Hasgaard M., Liu H., Soffer-Tsur N., Cohen K., et al. Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response. JControl Release 2011, 156:231-238.
22. Rivkin I., Cohen K., Koffler J., Melikhov D., Peer D., Margalit R. Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors. Biomaterials 2010, 31:7106-7114.
23. Ossipov D.A. Nanostructured hyaluronic acid-based materials for active delivery to cancer. Expert Opin Drug Deliv 2010, 7:681-703.
24. Manju S., Sreenivasan K. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells. Langmuir 2011, 27:14489-14496.
25. Jaracz S., Chen J., Kuznetsova L.V., Ojima I. Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem 2005, 13:5043-5054.
26. Park W., Kim K.S., Bae B.C., Kim Y.H., Na K. Cancer cell specific targeting of nanogels from acetylated hyaluronic acid with low molecular weight. Eur J Pharm Sci 2010, 40:367-375.
27. Pitarresi G., Palumbo F.S., Albanese A., Fiorica C., Picone P., Giammona G. Self-assembled amphiphilic hyaluronic acid graft copolymers for targeted release of antitumoral drug. JDrug Target 2010, 18:264-276.
28. Liu Y., Sun J., Zhang P., He Z. Amphiphilic polysaccharide-hydrophobicized graft polymeric micelles for drug delivery nanosystems. Curr Med Chem 2011, 18:2638-2648.
29. Jeong Y.I., Kim do H., Chung C.W., Yoo J.J., Choi K.H., Kim C.H., et al. Self-assembled nanoparticles of hyaluronic acid/poly(dl-lactide-co-glycolide) block copolymer. Colloids Surf B Biointerfaces 2012, 90:28-35.
30. Yadav A.K., Agarwal A., Rai G., Mishra P., Jain S., Mishra A.K., et al. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil. Drug Deliv 2010, 17:561-572.
31. Yadav A.K., Mishra P., Mishra A.K., Jain S., Agrawal G.P. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Nanomedicine 2007, 3:246-257.
32. Zille H., Paquet J., Henrionnet C., Scala-Bertola J., Leonard M., Six J.L., et al. Evaluation of intra-articular delivery of hyaluronic acid functionalized biopolymeric nanoparticles in healthy rat knees. Biomed Mater Eng 2010, 20:235-242.
33. Lee H., Ahn C.H., Park T.G. Poly[lactic-co-(glycolic acid)]-grafted hyaluronic acid copolymer micelle nanoparticles for target-specific delivery of doxorubicin. Macromol Biosci 2009, 9:336-342.
34. Upadhyay K.K., Le Meins J.F., Misra A., Voisin P., Bouchaud V., Ibarboure E., et al. Biomimetic doxorubicin loaded polymersomes from hyaluronan-block-poly(gamma-benzyl glutamate) copolymers. Biomacromolecules 2009, 10:2802-2808.
35. Cheng J., Teply B.A., Sherifi I., Sung J., Luther G., Gu F.X., et al. Formulation of functionalized PLGA-PEG nanoparticles for invivo targeted drug delivery. Biomaterials 2007, 28:869-876.
36. Shahin M., Lavasanifar A. Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery. Int J Pharm 2010, 389:213-222.
37. Chen M., Le D.Q., Baatrup A., Nygaard J.V., Hein S., Bjerre L., et al. Self-assembled composite matrix in a hierarchical 3-D scaffold for bone tissue engineering. Acta Biomater 2011, 7:2244-2255.
38. Li J., Huo M., Wang J., Zhou J., Mohammad J.M., Zhang Y., et al. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. Biomaterials 2012, 33:2310-2320.
39. Saravanakumar G., Choi K.Y., Yoon H.Y., Kim K., Park J.H., Kwon I.C., et al. Hydrotropic hyaluronic acid conjugates: synthesis, characterization, and implications as a carrier of paclitaxel. Int J Pharm 2010, 394:154-161.
40. Gaucher G., Dufresne M.H., Sant V.P., Kang N., Maysinger D., Leroux J.C. Block copolymer micelles: preparation, characterization and application in drug delivery. JControl Release 2005, 109:169-188.
41. Sun B., Feng S.S. Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel. Nanomedicine (Lond) 2009, 4:431-445.
42. Muthu M.S., Kulkarni S.A., Xiong J., Feng S.S. Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int J Pharm 2011, 421:332-340.